Annexon, Inc.
NASDAQ:ANNXBiotechnology
Healthcare
$3.52 -0.71%
-$0.04 today
- Market cap
- $576.73M
- Beta
- 1.18
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.01
52W Low $1.85High $7.18
Volume 2.98M
Average 2.56M
Balance Sheet
Inspect the capital base behind the business.
Assets
$277.57M
FY 2025 · Annual
-20.7% YoYLiabilities
$65.92M
FY 2025 · Annual
+15.7% YoYEquity
$211.65M
FY 2025 · Annual
-27.8% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 74.84M | 140.02M | 225.11M | 49.5M | 162.05M |
| Short-term Investments | 167.87M | 102.64M | 34.61M | 262.52M | 76.29M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 463K | 203K | 63K | 1.1M | 1.24M |
| Total Current Assets | 247.69M | 248.1M | 263.86M | 316.46M | 242.19M |
| Property, Plant & Equipment (Net) | 38.18M | 35.97M | 32.78M | 29.34M | 25.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 1.03M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.17M | 1.03M | 1.03M | 4.27M | 9.58M |
| Total Non-current Assets | 39.35M | 37M | 33.81M | 33.61M | 35.38M |
| Total Assets | 287.04M | 285.1M | 297.67M | 350.07M | 277.57M |
| Account Payables | 11.15M | 7.42M | 5.49M | 10.43M | 14.93M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.06M | 180K | 5.65M | 5.97M | 8.03M |
| Total Current Liabilities | 21.74M | 22.36M | 17.93M | 30.51M | 42.63M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 33.39M | 31.54M | 29.19M | 26.45M | 23.29M |
| Total Liabilities | 55.13M | 53.9M | 47.12M | 56.97M | 65.92M |
| Common Stock | 39K | 48K | 78K | 109K | 149K |
| Retained Earnings | (296.32M) | (438.26M) | (572.5M) | (710.7M) | (917.39M) |
| Accumulated OCI | (180K) | (372K) | (52K) | 10K | (29K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 231.91M | 231.19M | 250.56M | 293.11M | 211.65M |
| Total Debt | 34.59M | 32.86M | 31.36M | 28.97M | 26.2M |
| Net Debt | (40.25M) | (107.16M) | (193.76M) | (20.53M) | (135.85M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $175.2M |
| Short-term Investments | $49.8M |
| Other Current | $3.2M |
| Total Current Assets | $228.3M |
| PP&E (Net) | $24.9M |
| Other Non-current | $9.7M |
| Total Non-current Assets | $34.6M |
| Total Assets | $262.9M |
Analysis
Selected assets total $262.9M for Latest. The largest visible component is Cash & Equivalents at $175.2M, about 66.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 25, 2026 | |
| 3 | Initial statement of beneficial ownership | Aug 12, 2026 |
How much cash does ANNX have?
Annexon, Inc. (ANNX) reported $162.05M in cash and equivalents in fiscal 2025.
How much debt does ANNX carry?
Annexon, Inc. (ANNX) reported $26.20M of total debt, with net debt of -$135.85M.
Continue the stock analysis
Jump to another research area for this company.